86983429 - X

Information

  • Trademark
  • 86983429
  • Serial Number
    86983429
  • Registration Number
    5375989
  • Filing Date
    July 16, 2014
    10 years ago
  • Registration Date
    January 09, 2018
    7 years ago
  • Transaction Date
    August 27, 2024
    5 months ago
  • Status Date
    July 22, 2024
    6 months ago
  • Published for Opposition Date
    April 05, 2016
    8 years ago
  • Location Date
    December 07, 2017
    7 years ago
  • First Use Anywhere Date
    August 01, 2010
    14 years ago
  • First Use In Commerce Date
    August 01, 2010
    14 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEATING, MICHAEL P
  • Attorney Docket Number
    048337-365
    Attorney Name
    Doyle Siever
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
4
Mark Identification
X
Case File Statements
  • GS0051: Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes
  • GS0011: Chemicals, biochemicals and reagents for use in industry and science; chemicals for use in biochemical and chemical industry; chemicals for use in agriculture except fungicides, herbicides, insecticides and parasiticides; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and protein receptors for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting gene expression; research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research
  • GS0421: Development of new technology for others in the field of medicine, genetics, therapeutics, biotechnology, and energy, fuels, biofuels, and agriculture; development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the chemical, biochemical, pharmaceutical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use as a web-based custom order and purchasing system for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use as a web-based custom order and purchasing system for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for generating and tracking orders in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site featuring technology that allows users to view, store, and manage data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology
Case File Event Statements
  • 7/19/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/22/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/12/2014 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/18/2014 - 10 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/18/2014 - 10 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/18/2014 - 10 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/18/2015 - 9 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/18/2015 - 9 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/18/2015 - 9 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/23/2015 - 9 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/23/2015 - 9 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/23/2015 - 9 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/29/2015 - 9 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 10/5/2015 - 9 years ago
    14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 2/12/2016 - 8 years ago
    15 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 2/12/2016 - 8 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/13/2016 - 8 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/2/2016 - 8 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/2/2016 - 8 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/16/2016 - 8 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/5/2016 - 8 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/5/2016 - 8 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/31/2016 - 8 years ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/22/2016 - 8 years ago
    24 - TEAS PETITION TO DIRECTOR RECEIVED Type: TPDR
  • 9/14/2016 - 8 years ago
    25 - ASSIGNED TO PETITION STAFF Type: APET
  • 9/16/2016 - 8 years ago
    26 - PETITION TO DIRECTOR DENIED Type: PCDE
  • 11/16/2016 - 8 years ago
    27 - TEAS PETITION TO DIRECTOR RECEIVED Type: TPDR
  • 11/23/2016 - 8 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/23/2016 - 8 years ago
    29 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/23/2016 - 8 years ago
    30 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/25/2016 - 8 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/27/2017 - 8 years ago
    32 - ASSIGNED TO PETITION STAFF Type: APET
  • 2/1/2017 - 8 years ago
    33 - ASSIGNED TO PETITION STAFF Type: APET
  • 3/30/2017 - 7 years ago
    34 - PETITION TO DIRECTOR DENIED Type: PCDE
  • 5/31/2017 - 7 years ago
    35 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/31/2017 - 7 years ago
    36 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/31/2017 - 7 years ago
    37 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/2/2017 - 7 years ago
    38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/26/2017 - 7 years ago
    39 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/28/2017 - 7 years ago
    40 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 11/28/2017 - 7 years ago
    41 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 11/28/2017 - 7 years ago
    43 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 11/28/2017 - 7 years ago
    45 - USE AMENDMENT FILED Type: IUAF
  • 12/4/2017 - 7 years ago
    42 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/5/2017 - 7 years ago
    44 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 12/5/2017 - 7 years ago
    46 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 12/7/2017 - 7 years ago
    47 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 4/16/2020 - 4 years ago
    51 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 12/8/2017 - 7 years ago
    48 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 1/9/2018 - 7 years ago
    49 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/8/2020 - 4 years ago
    50 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/16/2020 - 4 years ago
    52 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/16/2020 - 4 years ago
    53 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/16/2020 - 4 years ago
    54 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 4/16/2020 - 4 years ago
    55 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/16/2020 - 4 years ago
    56 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/9/2020 - 4 years ago
    57 - REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Type: CORV
  • 1/9/2023 - 2 years ago
    58 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 7/22/2024 - 6 months ago
    61 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 2/7/2024 - 12 months ago
    60 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 2/7/2024 - 12 months ago
    59 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK